Answers are grounded in this paper and cite their sources.
Cohort study shows improved survival in advanced cancers when therapies align with genomic biomarkers, suggesting an evidence-based approach.
In this cohort study of patients with advanced solid tumors, matching therapies to genomic biomarkers was associated with improved survival only when supported by prospective clinical trial evidence. These findings support using an evidence-based framework to prioritize genomically guided therapies.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: